Rokit Genomics Files Five Foundational Patents for Organ Rejuvenation Platform
Building an Epigenetics-Based Patent Portfolio Targeting Lung, Liver, Skin, Retina, and Kidney
Collaboration With Algenomics to Integrate circRNA and AI Bioprinting
Rokit Healthcare announced on July 16 that its subsidiary, Rokit Genomics, has filed five original patents for an epigenetics-based organ rejuvenation platform targeting the lung, liver, skin, retina, and kidney.
This patent covers a platform technology that controls organ-specific aging mechanisms epigenetically. The company explained that it has built a customized development platform for each organ by reflecting variables such as chromatin accessibility, histone modification, DNA methylation patterns, and tissue-specific transcription factor binding sites.
Rokit Genomics stated that, unlike conventional gene-editing methods such as CRISPR-Cas9 that directly cut DNA, this technology features reversible regulation of target gene expression, thereby reducing the risk of permanent genetic changes. Through this, it can be used to regulate impaired metabolic processes related to aging such as glucose and lipid metabolism, inflammation, and oxidative stress.
The company noted that, considering that the epigenetic environment of the same gene varies by organ, it has developed optimized technologies for specific organs including the lung, liver, and kidney. They expect this design to translate into patent competitiveness.
To commercialize the technology, Rokit Genomics signed a memorandum of understanding (MOU) with RNA-based gene therapy company Algenomics. The two companies are pursuing a plan to combine Rokit Genomics' epigenetics-based rejuvenation technology with Algenomics’ circular RNA (circRNA) platform. In addition, they plan to incorporate Rokit Healthcare’s AI-based bioprinting technology to develop an organ regeneration platform.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
A representative from Rokit Healthcare stated, "We will expand opportunities for joint research and technology transfer based on the safety and reversibility of epigenetics-based rejuvenation technology."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.